Diagnoly is an AI-powered medical hardware device for prenatal detection of fetal abnormalities in real-time.
Diagnoly has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Diagnoly's investors include XAnge, Newfund, MassChallenge Switzerland, Mutuelles Impact, Les Business Angels des Grandes Écoles.
Diagnoly is headquartered in Lyon, France.
Diagnoly is an AI-powered medical hardware device for prenatal detection of fetal abnormalities in real-time.
Diagnoly is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Diagnoly — Funding & Investors." VCBacked, April 8, 2025, https://www.vcbacked.co/company/diagnoly. Accessed October 31, 2026.
VCBacked. (2025). Diagnoly — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/diagnoly
{{cite web |title=Diagnoly — Funding & Investors |url=https://www.vcbacked.co/company/diagnoly |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated